Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event
Clinical trial NCT00347217 · COMPLETED
Trial details
- NCT number
- NCT00347217
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2006-02-01
- Enrollment
- 3840
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.